German Spondyloarthritis Inception Cohort
-
- STATUS
- Recruiting
-
- End date
- Jul 22, 2030
-
- participants needed
- 1000
-
- sponsor
- Charite University, Berlin, Germany
Summary
The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.
Details
| Condition | Ankylosing Spondylitis, Ulcerative Colitis, Ankylosing spondylitis, Non-radiographic Axial Spondyloarthritis, Non-radiographic Axial Spondyloarthritis (Nr-axSpA), Axial Psoriatic Arthritis (axPsA), Inflammatory Bowel Disease, Inflammatory bowel disease, Ulcerative Colitis (Pediatric), acute anterior uveitis, Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Crohn's Disease (Pediatric), Crohn's Disease, crohns disease |
|---|---|
| Clinical Study Identifier | NCT01277419 |
| Sponsor | Charite University, Berlin, Germany |
| Last Modified on | 22 October 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer